During which gestational weeks does organogenesis (organ formation) occur?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Organogenesis Occurs Primarily at 5-8 Weeks of Gestation

Organ formation (organogenesis) develops primarily during gestational weeks 5-8, with this critical period representing the time of greatest vulnerability to teratogenic exposures and congenital anomalies. 1, 2, 3

Critical Developmental Timeline

The evidence from multiple American Diabetes Association guidelines consistently identifies weeks 5-8 of gestation as the primary window for organogenesis 1, 2, 3. This timing is clinically crucial because:

  • Elevated glucose levels during the first 10 weeks of pregnancy are directly proportional to increased risk of diabetic embryopathy, including anencephaly, microcephaly, congenital heart disease, renal anomalies, and caudal regression 1, 2, 3

  • A1C levels <6.5% achieved prior to conception are associated with the lowest risk of congenital anomalies, preeclampsia, and preterm birth 1, 2, 3

Extended Developmental Context

While the core organogenesis window is 5-8 weeks, organ development follows a broader timeline:

  • Week 3-4: Initial organ primordia begin to emerge, with the liver appearing around the third week of gestation 4
  • Weeks 5-8: Primary organogenesis with rapid proliferation and differentiation of major organ systems 1, 2, 3
  • Weeks 4-9: Human kidney development initiates around 4 weeks 5
  • Through week 10: Continued vulnerability to teratogenic effects, particularly for neural and cardiac structures 1

Clinical Implications for Medication Safety

Chemotherapy and teratogenic medications are contraindicated during the first trimester specifically to avoid interference with organogenesis, with a 10-20% risk of major malformations if exposed during this period 6. After 14 weeks of gestation, certain chemotherapy agents become relatively safer as organogenesis is largely complete 6.

The first trimester represents the most critical time for concern about potential congenital malformation from any medication exposure 7, reinforcing that organogenesis is the key developmental process during this window.

Common Pitfalls

  • Do not confuse gestational age (from last menstrual period) with embryonic/fetal age (from conception)—the 5-8 week window refers to gestational age
  • The vulnerability extends through the first 10 weeks, not just weeks 5-8, though peak organogenesis occurs in the 5-8 week window
  • Different organ systems have slightly different critical periods within this overall timeframe (e.g., cardiac development, neural tube closure)

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.